TGFB1 antibody (AA 30-278) (APC)

Catalog No. ABIN598169

Product Details anti-TGFB1 Antibody (APC)

Target: TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))

Binding Specificity: AA 30-278

Reactivity: Human, Mouse

Host: Mouse

Clonality: Monoclonal

Conjugate: This TGFB1 antibody is conjugated to APC

Application: Flow Cytometry (FACS)

Specificity: Recognizes human TGF-beta 1. Species cross-reactivity: mouse.

Purification: Immunoaffinity purified

Immunogen: Sf 21-derived recombinant human latency associated peptide of TGf-beta1 (rhLAP (aa30-278, Accession# P01137.2).

Isotype: IgG1

Application Details

Application Notes: Approved: Flo

Usage: Suitable for use in Flow Cytometry. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: Sodium chloride, 0.5 % BSA, 0.1 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Do not freeze! Freezing Allophycocyanin conjugates will result in a substantial loss of enzymatic activity.

Storage: 4 °C

Storage Comment: May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for at least 1 year. Freezing Allophycocyanin conjugates will result in a substantial loss of enzymatic activity.

Target Details for TGFB1

Target: TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))

Alternative Name: TGFB1 / TGF Beta 1 (TGFB1 Products)

Background: Name/Gene ID: TGFB1
Family: TGF beta

Synonyms: TGFB1, CED, DPD1, Diaphyseal dysplasia 1, LAP, Latency-associated peptide, TGF Beta, TGFbeta, TGF-beta 1 protein, TGF-beta-1, TGFB

Gene ID: 7040

UniProt: P01137

Pathways: EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints